Diabetes

1. EVANS-MOLINA C
   The Ailing beta-Cell in Diabetes: Insights From a Trip to the ER: The 2023 Outstanding Scientific Achievement Award Lecture.
   Diabetes. 2024;73:545-553.
   

   >> Share

   
   
2. DRAWSHY Z, Neiman D, Fridlich O, Peretz A, et al
   DNA Methylation-Based Assessment of Cell Composition in Human Pancreas and Islets.
   Diabetes. 2024;73:554-564.
   

   >> Share

   
   
3. LAI SWT, Hernandez-Castillo C, De Jesus Lopez Gonzalez E, Zoukari T, et al
   Methylglyoxal adducts are prognostic biomarkers for diabetic kidney disease in patients with type 1 diabetes.
   Diabetes. 2023 Nov 15:db230277. doi: 10.2337/db23-0277.
   

   >> Share

   
   

   
   Intern Med

4. KIRITO K
   Silent Thyroiditis Associated with Ropeginterferon alpha-2b in a Patient with Polycythemia Vera.
   Intern Med. 2024;63:843-846.
   

   >> Share

   
   

   
   J Autoimmun

5. WANG Y, Wang S, Liu W, Gu H, et al
   Anti-DNA antibody-targeted D-peptide nanoparticles ameliorate lupus nephritis in MRL/lpr mice.
   J Autoimmun. 2024;145:103205.
   

   >> Share

   
   

   
   J Clin Endocrinol Metab

6. UHL S, Choure A, Rouse B, Loblack A, et al
   Effectiveness of Continuous Glucose Monitoring on Metrics of Glycemic Control in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
   J Clin Endocrinol Metab. 2023 Nov 21:dgad652. doi: 10.1210.
   

   >> Share

   
   
7. THORNTON PS, De Leon DD, Empting S, Zangen D, et al
   Dasiglucagon for the Treatment of Congenital Hyperinsulinism: A Randomized Phase 3 Trial in Infants and Children.
   J Clin Endocrinol Metab. 2024;109:1071-1079.
   

   >> Share

   
   
8. BROWN N, Elston MS
   Systematic Review-Type B Insulin Resistance With Isolated Hypoglycemia and Suppressed Insulin.
   J Clin Endocrinol Metab. 2024;109:936-943.
   

   >> Share

   
   

   
   J Immunol

9. WU J, Han K, Sack MN
   Targeting NAD+ Metabolism to Modulate Autoimmunity and Inflammation.
   J Immunol. 2024;212:1043-1050.
   

   >> Share

   
   
10. COSTANZO A, Clarke D, Holt M, Sharma S, et al
    Repositioning the Early Pathology of Type 1 Diabetes to the Extraislet Vasculature.
    J Immunol. 2024 Mar 1:ji2300769. doi: 10.4049/jimmunol.2300769.
    

    >> Share

    
    

    
    J Nephrol

11. REN W, Sun J, Zhang L, He W, et al
    Significance of the total renal chronicity score in predicting renal outcome in PLA2R-associated membranous nephropathy.
    J Nephrol. 2024 Mar 21. doi: 10.1007/s40620-024-01893.
    

    >> Share

    
    

    
    J Neuroimmunol

12. CHANG EH, Hardy TA
    Peripheral oedema as an adverse effect of treatment of secondary progressive multiple sclerosis with siponimod: A case series.
    J Neuroimmunol. 2024;389:578330.
    

    >> Share

    
    

    
    J Neurol

13. ALBERGONI M, Pagani E, Preziosa P, Meani A, et al
    Thalamic nuclei volume partially mediates the effects of aerobic capacity on fatigue in people with multiple sclerosis.
    J Neurol. 2024 Mar 20. doi: 10.1007/s00415-024-12277.
    

    >> Share

    
    
14. ABDELGAIED MY, Rashad MH, El-Tayebi HM, Solayman MH, et al
    Correction to: The impact of metformin use on the outcomes of relapse?remitting multiple sclerosis patients receiving interferon beta 1a: an exploratory prospective phase II open?label randomized controlled trial.
    J Neurol. 2024 Mar 18. doi: 10.1007/s00415-024-12249.
    

    >> Share

    
    

    
    J Rheumatol

15. YAMAMOTO H, Taniguchi Y
    Cranial Giant Cell Arteritis and Subdural Hematoma.
    J Rheumatol. 2024 Mar 15:jrheum.2024-0008. doi: 10.3899/jrheum.2024-0008.
    

    >> Share

    
    

    
    Mult Scler

16. CAMPAGNA MP, Havrdova EK, Horakova D, Izquierdo G, et al
    No evidence for association between rs10191329 severity locus and longitudinal disease severity in 1813 relapse-onset multiple sclerosis patients from the MSBase registry.
    Mult Scler. 2024 Mar 21:13524585241240406. doi: 10.1177/13524585241240406.
    

    >> Share

    
    
17. HJALGRIM H, Rostgaard K
    Infectious mononucleosis and risk of multiple sclerosis: Proxy or culprit?
    Mult Scler. 2024 Mar 21:13524585241237708. doi: 10.1177/13524585241237708.
    

    >> Share

    
    
18. GOLDACRE R
    Risk of multiple sclerosis in individuals with infectious mononucleosis: a national population-based cohort study using hospital records in England, 2003-2023.
    Mult Scler. 2024 Mar 21:13524585241237707. doi: 10.1177/13524585241237707.
    

    >> Share

    
    

    
    N Engl J Med

19. NETEA MG, van de Veerdonk FL
    Anti-Interleukin-23 Autoantibodies and Severe Infections.
    N Engl J Med. 2024;390:1143-1146.
    

    >> Share

    
    
20. CHENG A, Kashyap A, Salvator H, Rosen LB, et al
    Anti-Interleukin-23 Autoantibodies in Adult-Onset Immunodeficiency.
    N Engl J Med. 2024;390:1105-1117.
    

    >> Share

    
    

    
    Neurology

21. AGYEI P, Chen M, Guo Y, Perez CA, et al
    Pearls & Oy-sters: KLHL11 IgG Paraneoplastic-Associated Hearing Loss and Rhombencephalitis in a Woman With Metastatic Mullerian Tumor.
    Neurology. 2024;102:e209187.
    

    >> Share

    
    
22. ZOUVELOU V, Petrou EM, Strataki E, Vasileiou V, et al
    Pearls & Oy-sters: Thyroid-Associated Ophthalmopathy and Transient Neuromuscular Junction Disorder Due to Graves Disease.
    Neurology. 2024;102:e209282.
    

    >> Share

    
    

    
    PLoS One

23. LIU Z, Fan T, Mo X, Kan J, et al
    Association between multiple sclerosis and cancer risk: A two-sample Mendelian randomization study.
    PLoS One. 2024;19:e0298271.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share